Materiality Analysis Help
| Environmental & Social Impact Materiality | |
|---|---|
| A. Scale of Impact (Severity) | |
| Score | Description (Healthcare context) |
| 1 | Negligible impact; no meaningful effect on patients, staff, community or environment. |
| 2 | Minor impact; limited, reversible issues affecting a small group (e.g., minor operational inefficiencies). |
| 3 | Moderate impact; noticeable effect on patient or staff experience, environmental performance or public health. |
| 4 | Major impact; serious implications for clinical safety, workforce well-being, environmental pollution, or trust. |
| 5 | Severe/critical impact; harm to patients, irreversible environmental damage, legal violations, reputational crisis. |
| B. Scope of Impact (Extent) | |
|---|---|
| Score | Description (Healthcare context) |
| 1 | Very limited scope; isolated to a small internal process or single team. |
| 2 | Localised scope; affects one department or a small patient subgroup. |
| 3 | Organisational scope; affects multiple units or a significant portion of staff/patients. |
| 4 | Wide scope; affects the entire organisation and multiple stakeholder groups. |
| 5 | Systemic scope; affects external community, broader public health systems or large population groups. |
| C. Irremediability (Reversibility) | |
|---|---|
| Score | Description (Healthcare context) |
| 1 | Fully reversible; no long-term effects. |
| 2 | Mostly reversible with minimal intervention. |
| 3 | Partially reversible; requires targeted investments or mitigation. |
| 4 | Difficult to reverse; long-term environmental or health consequences. |
| 5 | Irreversible; permanent damage to people, public health or the environment. |
| T.S. | Interpretation |
|---|---|
| 13–15 | Highly Material – Critical issue with substantial impact on patients, staff, public health or the environment. Must be disclosed. |
| 10–12 | Material – Significant impact that warrants mandatory ESRS disclosure. |
| 7–9 | Needs Monitoring / Context-Specific – Potentially material depending on value chain, scale, or regulatory environment. |
| 3–6 | Non-Material – Limited impact, minimal relevance for ESRS disclosure. |
| Financial Materiality | |
|---|---|
| Financial Magnitude (Impact on OPEX, CAPEX, Revenues) | |
| Score | Description (Healthcare context) |
| 1 | Negligible financial effect; no relevant impact on OPEX or CAPEX. |
| 2 | Minor cost impact; manageable without budget changes. |
| 3 | Moderate financial effect requiring budget adjustments or operational changes. |
| 4 | Significant economic burden requiring substantial investment or resource reallocation. |
| 5 | Very high financial impact threatening sustainability, liquidity, or access to funding. |
| Regulatory & Compliance Risk (Exposure to Fines, Audits, Legal Risks) | |
|---|---|
| Score | Description (Healthcare context) |
| 1 | Minimal regulatory exposure. No risk of fines or material non-conformities. |
| 2 | Low-level obligations; small risk of minor audit findings. |
| 3 | Existing compliance obligations; non-conformity could lead to moderate findings or penalties. |
| 4 | High regulatory pressure; material risk of fines, accreditation loss, or legal consequences. |
| 5 | Critical regulatory exposure; non-compliance may cause shutdowns, license risks, or major sanctions. |
| Strategic & Reputational Impact (Effect on Trust, Accreditation, and Competitiveness) | |
|---|---|
| Score | Description (Healthcare context) |
| 1 | No strategic or reputational relevance. |
| 2 | Limited impact on specific internal or external groups. |
| 3 | Noticeable impact on hospital reputation or staff/patient perceptions, but manageable. |
| 4 | Significant damage to trust; may affect accreditation or financial performance. |
| 5 | Severe harm to reputation, accreditation, competitiveness, or public trust. |
| T.S. | Interpretation |
|---|---|
| 13–15 | Highly Material – The topic poses substantial financial implications. It may require significant investment, carries high regulatory and legal exposure, or presents critical reputational risks affecting patient trust, accreditation, and long-term financial resilience. Must be disclosed under ESRS. |
| 10–12 | Financially Material – The topic has clear and measurable financial relevance. It affects budget planning, compliance obligations, or strategic positioning. Should be disclosed unless strong evidence suggests otherwise. |
| 7–9 | Potentially Material / Monitor – The topic presents moderate financial relevance. It may not currently be material, but future regulatory changes, sector trends, or stakeholder expectations may elevate its importance. Requires regular monitoring and reassessment. |
| 3–6 | Not Financially Material – The topic shows limited financial significance. No major financial exposure or strategic implications at present. Does not require ESRS financial disclosure, though it may still be relevant for impact materiality. |